1 / 17

Improving Cancer Outcomes in Nottingham City

Facilitator: Dr Safiy Karim MBA, MPH, MMedSci (Ed), FRCGP GP, Robin Hood Cluster Chairman, CCG exec member and Cancer Lead Tuesday 17 th and 24 th April 2012. Improving Cancer Outcomes in Nottingham City. 12.30-1.15 – registration and lunch 1.30- 1.50pm – Cancer diagnosis in primary care

rholz
Télécharger la présentation

Improving Cancer Outcomes in Nottingham City

An Image/Link below is provided (as is) to download presentation Download Policy: Content on the Website is provided to you AS IS for your information and personal use and may not be sold / licensed / shared on other websites without getting consent from its author. Content is provided to you AS IS for your information and personal use only. Download presentation by click this link. While downloading, if for some reason you are not able to download a presentation, the publisher may have deleted the file from their server. During download, if you can't get a presentation, the file might be deleted by the publisher.

E N D

Presentation Transcript

  1. Facilitator: Dr Safiy KarimMBA, MPH, MMedSci (Ed), FRCGPGP, Robin Hood Cluster Chairman, CCG exec member and Cancer LeadTuesday 17th and 24th April 2012. • Improving Cancer Outcomes in Nottingham City

  2. 12.30-1.15 – registration and lunch 1.30- 1.50pm – Cancer diagnosis in primary care by Dr Safiy Karim 1.50-2.15 – Cancer- how are we performing? Public Health Consultant reflections - Alison Challenger/Julie O'Boyle 2.15- 2.45 – Grab some tea/coffee and facilitated small group discussion 2.45pm – general feedback and Q&A 3-3.20pm – Early palliative care intervention by Dr Andrew Wilcock 3.20-3.40pm – Guidelines and practice by Dr David Baldwin 3.40- 3.55pm – Views from a patient 4-4.30pm – Summary of the day, Q&A – Dr Safiy Karim Overview of the PLT

  3. To have an understanding on Cancer in Nottingham and of the impact of early diagnosis from national audit results How performance indicators show the ‘where we are now’ position in Nottingham What can be done when we keep patients at the centre of cancer healthcare Innovations in diagnosis and management Authorisation and 360 degree feedback. Aims and Objectives

  4. Survival • One year survival – • Early elective diagnosis • Five year survival- • Impact of treatment and early diagnosis too.

  5. Acknowledge – Durham University, Department of Health, National Cancer Intelligence network (NCIN), National Cancer Action Team and the RCGP. 20/28 cancer networks, 1170/8245 practices, 18,879 patients with cancer Excluded screen detected cases, non melanoma skin cancers and in-situ tumours Results from the nationalaudit of cancer diagnosis in Primary care 2009/2010.

  6. >66% of all patients referred within one month of seeing GP Those who saw GP, 75% after 1-2 attendances More advanced cancers found in Communication challenges Housebound Emergency presentations Better access to investigations would change GP management in 6% of cases- Brain, Ovary, Pancreas, Kidney, Lung Key take away messages

  7. Cancer sites for which >20% of patients had >3 consultations were Lung, Ovary, Pancreas, Lymphoma and Stomach 50.8% men and 57.3% women were via 2 week wait 17.1% men and 12.2% women – routine 13.2 men and 12.7% women - emergency GP challenges

  8. What is the cancer stage at diagnosis?

  9. Early detection ofcancer • Time to re-frame this as… • A medical emergency? • What does added years or life to years mean?

  10. The Health and Social Care Act As a clinical commissioning group (CCG), you will have the freedom to use the NHS budget in the best interests of your patients. You will have the freedom to structure your CCG in the way that ensures all of your constituent practices – and through them, their patients – have a direct influence on the way the NHS budget is spent. You will also have the freedom to pursue innovative ways of delivering care that delivers better results for your patients.

  11. ………..can I have a blood in the urine poster? Involve employers,Tricks or Tweets

  12. Forest performanceimproves post CCG.

  13. Be visible; score goals

  14. Inform and involve

  15. Practices to review screening rates for breast, cervical & bowel cancer and compare performance against the cluster rates, city-wide rates and national rates Practices to discuss with patients at a practices patient participation group meeting or through a patient questionnaire the importance of screening and ask for their views/concerns Practices to develop an action plan to improve practice screening rates (by targeting non attenders), implement plan and monitor results. Cancer PSO (citywide) &patient engagement - 30p

  16. To have an understanding on Cancer in Nottingham and of the impact of early diagnosis from national audit results What can be done when we keep patients at the centre of cancer healthcare How performance indicators show the ‘where we are now’ position in Nottingham Innovations in diagnosis and management Authorisation and 360 degree feedback. Aims and Objectives

More Related